prednisolone has been researched along with Thyrotoxicosis in 23 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Thyrotoxicosis: A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amiodarone-induced thyrotoxicosis (AIT) is a complex therapeutic challenge." | 9.10 | A stepwise approach to the treatment of amiodarone-induced thyrotoxicosis. ( Başkal, N; Erdogan, G; Erdogan, MF; Güleç, S; Tutar, E, 2003) |
| " He was diagnosed with atrial fibrillation 2 years previously and started on amiodarone and warfarin." | 7.80 | Amiodarone-induced thyrotoxicosis: type 1 or type 2? ( Khan, A; Puttanna, A; Raskauskiene, D, 2014) |
| "Amiodarone-induced thyrotoxicosis (AIT) with features consistent with both AIT type I (in which thyroid antibodies and nodular goiter are present) and AIT type II (which is not responsive to thionamide therapy and eventually leads to permanent hypothyroidism)." | 7.74 | Treatment of amiodarone-associated thyrotoxicosis. ( Franklyn, JA; Gammage, MD, 2007) |
| "Amiodarone-induced thyrotoxicosis (AIT) type 1 occurs in subjects with an underlying thyroid disease, whereas type 2 AIT is a form of destructive thyroiditis." | 7.73 | Amiodarone-induced thyrotoxicosis due to destructive thyroiditis: therapeutic recommendations. ( Dietlein, M; Schicha, H, 2005) |
| "Current thinking is that amiodarone-induced thyrotoxicosis (AIT) might be either iodine-induced thyrotoxicosis in latent hyperthyroidism (Type 1) or destructive thyroiditis (Type 2), and also that colour-flow Doppler sonography (CFDS) of the thyroid and serum interleukin 6 (IL-6) are tools that can classify AIT and direct treatment." | 7.71 | Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography. ( Bennet, WM; Eaton, SE; Euinton, HA; Newman, CM; Weetman, AP, 2002) |
| "We report two patients whose thyrotoxicosis failed to respond to conventional treatment with carbimazole." | 7.69 | Treatment of thyrotoxicosis resistant to carbimazole with corticosteroids. ( Dale, J; Dodson, PM; Jude, EB; Kumar, S, 1996) |
| "We describe a patient who was treated with amiodarone for ventricular arrhythmia based on arrhythmogenic right ventricular dysplasia and who subsequently developed severe amiodarone-induced thyrotoxicosis." | 7.69 | A case of amiodarone-induced thyrotoxicosis successfully treated with prednisolone. ( Hayashi, K; Kondoh, J; Numaguchi, Y; Sassa, H; Sone, T; Suzuki, T; Tsuboi, H, 1997) |
| "Amiodarone is a widely used anti-arrhythmic drug." | 5.40 | An audit of amiodarone-induced thyrotoxicosis--do anti-thyroid drugs alone provide adequate treatment? ( Inder, WJ; Kaye, G; Patel, N; Sullivan, C, 2014) |
| "Amiodarone-induced thyrotoxicosis (AIT) is a complex therapeutic challenge." | 5.10 | A stepwise approach to the treatment of amiodarone-induced thyrotoxicosis. ( Başkal, N; Erdogan, G; Erdogan, MF; Güleç, S; Tutar, E, 2003) |
| " He was diagnosed with atrial fibrillation 2 years previously and started on amiodarone and warfarin." | 3.80 | Amiodarone-induced thyrotoxicosis: type 1 or type 2? ( Khan, A; Puttanna, A; Raskauskiene, D, 2014) |
| " He improved rapidly but went on to develop hypothyroidism on follow-up and required levothyroxine replacement." | 3.75 | An uncommon endocrine cause of pyrexia of unknown origin. ( Alexander, V; Chattopadhyay, A; Kurien, TT, 2009) |
| "Amiodarone-induced thyrotoxicosis (AIT) with features consistent with both AIT type I (in which thyroid antibodies and nodular goiter are present) and AIT type II (which is not responsive to thionamide therapy and eventually leads to permanent hypothyroidism)." | 3.74 | Treatment of amiodarone-associated thyrotoxicosis. ( Franklyn, JA; Gammage, MD, 2007) |
| "Amiodarone-induced thyrotoxicosis (AIT) type 1 occurs in subjects with an underlying thyroid disease, whereas type 2 AIT is a form of destructive thyroiditis." | 3.73 | Amiodarone-induced thyrotoxicosis due to destructive thyroiditis: therapeutic recommendations. ( Dietlein, M; Schicha, H, 2005) |
| "Current thinking is that amiodarone-induced thyrotoxicosis (AIT) might be either iodine-induced thyrotoxicosis in latent hyperthyroidism (Type 1) or destructive thyroiditis (Type 2), and also that colour-flow Doppler sonography (CFDS) of the thyroid and serum interleukin 6 (IL-6) are tools that can classify AIT and direct treatment." | 3.71 | Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography. ( Bennet, WM; Eaton, SE; Euinton, HA; Newman, CM; Weetman, AP, 2002) |
| "We report two patients whose thyrotoxicosis failed to respond to conventional treatment with carbimazole." | 3.69 | Treatment of thyrotoxicosis resistant to carbimazole with corticosteroids. ( Dale, J; Dodson, PM; Jude, EB; Kumar, S, 1996) |
| "We describe a patient who was treated with amiodarone for ventricular arrhythmia based on arrhythmogenic right ventricular dysplasia and who subsequently developed severe amiodarone-induced thyrotoxicosis." | 3.69 | A case of amiodarone-induced thyrotoxicosis successfully treated with prednisolone. ( Hayashi, K; Kondoh, J; Numaguchi, Y; Sassa, H; Sone, T; Suzuki, T; Tsuboi, H, 1997) |
| "Amiodarone is a widely used anti-arrhythmic drug." | 1.40 | An audit of amiodarone-induced thyrotoxicosis--do anti-thyroid drugs alone provide adequate treatment? ( Inder, WJ; Kaye, G; Patel, N; Sullivan, C, 2014) |
| "TINU syndrome with hyperthyroidism is rare." | 1.36 | [Adult male with tubulointerstitial nephritis and uveitis syndrome complicated with thyroiditis]. ( Fujii, T; Iwamoto, S; Kakei, S; Matsui, N; Tanaka, H; Toda, T, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.70) | 18.7374 |
| 1990's | 9 (39.13) | 18.2507 |
| 2000's | 7 (30.43) | 29.6817 |
| 2010's | 5 (21.74) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jolobe, OMP | 1 |
| Jamieson, A | 1 |
| Patel, N | 1 |
| Inder, WJ | 1 |
| Sullivan, C | 1 |
| Kaye, G | 1 |
| Khan, A | 1 |
| Puttanna, A | 1 |
| Raskauskiene, D | 1 |
| Alexander, V | 1 |
| Kurien, TT | 1 |
| Chattopadhyay, A | 1 |
| Iwamoto, S | 1 |
| Kakei, S | 1 |
| Tanaka, H | 1 |
| Fujii, T | 1 |
| Toda, T | 1 |
| Matsui, N | 1 |
| Arvola, T | 1 |
| Mustalahti, K | 1 |
| Saha, MT | 1 |
| Vehmanen, P | 1 |
| Partanen, J | 1 |
| Ashorn, M | 1 |
| Erdogan, MF | 1 |
| Güleç, S | 1 |
| Tutar, E | 1 |
| Başkal, N | 1 |
| Erdogan, G | 1 |
| FROLOVA, AI | 1 |
| Dietlein, M | 1 |
| Schicha, H | 1 |
| Sato, K | 2 |
| Franklyn, JA | 1 |
| Gammage, MD | 1 |
| Iaizzo, PA | 1 |
| Quasthoff, S | 1 |
| Lehmann-Horn, F | 1 |
| Jude, EB | 1 |
| Dale, J | 1 |
| Kumar, S | 1 |
| Dodson, PM | 1 |
| van Dam, GM | 1 |
| Reisman, Y | 1 |
| van Wieringen, K | 1 |
| Hayashi, K | 1 |
| Sone, T | 1 |
| Suzuki, T | 1 |
| Numaguchi, Y | 1 |
| Kondoh, J | 1 |
| Tsuboi, H | 1 |
| Sassa, H | 1 |
| Rink, T | 1 |
| Wieg, C | 1 |
| Schroth, HJ | 1 |
| Helisch, A | 1 |
| Bertram, U | 1 |
| Miyakawa, M | 1 |
| Eto, M | 1 |
| Inaba, T | 1 |
| Matsuda, N | 1 |
| Shiga, T | 1 |
| Ohnishi, S | 1 |
| Kasanuki, H | 1 |
| Eaton, SE | 1 |
| Euinton, HA | 1 |
| Newman, CM | 1 |
| Weetman, AP | 1 |
| Bennet, WM | 1 |
| Mercer, M | 1 |
| Balazs, C | 1 |
| Farid, NR | 1 |
| Shrivastava, MP | 1 |
| Datta, TK | 1 |
| Madiajagne, R | 1 |
| Epishin, AV | 1 |
| Epishina, NA | 1 |
| Solomko, LD | 1 |
| Kuz'min, IuP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multi-center, Open Label, Randomised Parallel- Group Study to Compare the Efficacy of Cholestyramine Plus Standard Treatment Versus Prednisolone Plus Standard Treatment Versus Standard Treatment Alone in Treatment of Overt Hyperthyroidism[NCT03303053] | Phase 3 | 135 participants (Anticipated) | Interventional | 2017-05-11 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for prednisolone and Thyrotoxicosis
| Article | Year |
|---|---|
[Drug (amiodarone)-induced thyroid disease].
Topics: Amiodarone; Hormone Replacement Therapy; Humans; Hypothyroidism; Perchlorates; Prednisolone; Thyroto | 2005 |
Hypokalaemic thyrotoxic periodic paralysis: case report and review of an Oriental syndrome.
Topics: Adrenergic beta-Antagonists; Adult; Anti-Inflammatory Agents; Antithyroid Agents; Humans; Hypokalemi | 1996 |
1 trial available for prednisolone and Thyrotoxicosis
| Article | Year |
|---|---|
A stepwise approach to the treatment of amiodarone-induced thyrotoxicosis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Antibodies; Antithyroid Agents; Female | 2003 |
20 other studies available for prednisolone and Thyrotoxicosis
| Article | Year |
|---|---|
Adrenal insufficiency - recognition and management.
Topics: Addison Disease; Adult; Aged; Antithyroid Agents; Carbimazole; Dose-Response Relationship, Drug; Fem | 2017 |
Drugs, the Thyroid, and the Heart: A Lethal Cocktail.
Topics: Agranulocytosis; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Atrial Fibrillation; Carbim | 2019 |
An audit of amiodarone-induced thyrotoxicosis--do anti-thyroid drugs alone provide adequate treatment?
Topics: Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Female; Glucocorticoids; Humans; Medical Aud | 2014 |
Amiodarone-induced thyrotoxicosis: type 1 or type 2?
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Atrial Fibrillation; Carbimazole; Gluc | 2014 |
An uncommon endocrine cause of pyrexia of unknown origin.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Biopsy, Fine-Needle; Drug Therapy, Combination; Feve | 2009 |
[Adult male with tubulointerstitial nephritis and uveitis syndrome complicated with thyroiditis].
Topics: Glucocorticoids; Humans; Hyperthyroidism; Male; Middle Aged; Nephritis, Interstitial; Prednisolone; | 2010 |
Celiac disease, thyrotoxicosis, and autoimmune hepatitis in a child.
Topics: Alanine Transaminase; Autoimmune Diseases; Celiac Disease; Child; Diet; Female; Gliadin; Glutens; Ha | 2002 |
[UROPEPSIN CONTENT IN PATIENTS WITH THYROTOXICOSIS AND OTHER DISEASES BEFORE AND AFTER THERAPY].
Topics: Drug Therapy; Endopeptidases; Gastric Acidity Determination; Humans; Hyperthyroidism; Hypothyroidism | 1964 |
Amiodarone-induced thyrotoxicosis due to destructive thyroiditis: therapeutic recommendations.
Topics: Adult; Aged; Amiodarone; Antithyroid Agents; Carbimazole; Drug Therapy, Combination; Female; Glucoco | 2005 |
Treatment of amiodarone-associated thyrotoxicosis.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Carbimazole; Hormone Replacement Therapy; Humans; Hypothyr | 2007 |
Differential diagnosis of periodic paralysis aided by in vitro myography.
Topics: Adult; Diagnosis, Differential; Epinephrine; Female; Humans; In Vitro Techniques; Lithium; Male; Mid | 1995 |
Treatment of thyrotoxicosis resistant to carbimazole with corticosteroids.
Topics: Adult; Antithyroid Agents; Carbimazole; Drug Resistance; Drug Therapy, Combination; Female; Humans; | 1996 |
A case of amiodarone-induced thyrotoxicosis successfully treated with prednisolone.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Humans; Male; Prednisolone; Tac | 1997 |
[Hyperthyroidism in a premature infant due to transplacental passage of maternal thyrotropin receptor antibodies].
Topics: Adult; Anti-Arrhythmia Agents; Antithyroid Agents; Autoantibodies; Carbimazole; Cardiotonic Agents; | 1999 |
Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Female; Humans; Hypothyroidism; | 1999 |
Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Antith | 2002 |
Amiodarone-induced thyrotoxicosis responding to oral steroid therapy.
Topics: Administration, Oral; Amiodarone; Humans; Male; Middle Aged; Prednisolone; Thyrotoxicosis | 1992 |
Soluble interleukin-2 receptor in sera of patients with Graves' disease.
Topics: Autoantibodies; Eye Diseases; Female; Graves Disease; Humans; Male; Methimazole; Prednisolone; Recep | 1991 |
Thyrotoxicosis with myasthenia--an unusual association.
Topics: Adult; Blepharoptosis; Carbimazole; Female; Humans; Myasthenia Gravis; Neostigmine; Prednisolone; Th | 1991 |
[Immunologically active preparations in the complex treatment of patients with diffuse toxic goiter].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Female; Humans; Levamisole; Male; Middle Aged; Prednisolo | 1988 |